Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma.

Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Yuan Y, Juarez-Garcia A, Tyas D, Pritchard C.

J Med Econ. 2019 Jan 14:1. doi: 10.1080/13696998.2019.1569446. [Epub ahead of print]

PMID:
30638416
2.

Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age.

Iyngkaran P, Liew D, Neil C, Driscoll A, Marwick TH, Hare DL.

Clin Med Insights Cardiol. 2018 Dec 4;12:1179546818809358. doi: 10.1177/1179546818809358. eCollection 2018.

3.

Impact of tobacco use on health and work productivity in Malaysia.

Tan QY, Zomer E, Owen AJ, Chin KL, Liew D.

Tob Control. 2019 Jan 4. pii: tobaccocontrol-2018-054677. doi: 10.1136/tobaccocontrol-2018-054677. [Epub ahead of print]

PMID:
30610080
4.

Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate.

Chin KL, Collier T, Pocock S, Pitt B, McMurray JJV, van Veldhuisen DJ, Swedberg K, Vincent J, Zannad F, Liew D.

Clin Res Cardiol. 2019 Jan 2. doi: 10.1007/s00392-018-1410-4. [Epub ahead of print]

PMID:
30604047
5.

Simultaneous analysis of haloacetonitriles, haloacetamides and halonitromethanes in chlorinated waters by gas chromatography-mass spectrometry.

Carter RAA, Liew DS, West N, Heitz A, Joll CA.

Chemosphere. 2018 Dec 12;220:314-323. doi: 10.1016/j.chemosphere.2018.12.069. [Epub ahead of print]

PMID:
30590297
6.

Patterns of Medication Dispensation for Multiple Comorbidities among Older Adults in Australia.

Ofori-Asenso R, Ilomaki J, Curtis AJ, Zomer E, Zoungas S, Liew D.

Pharmacy (Basel). 2018 Dec 17;6(4). pii: E134. doi: 10.3390/pharmacy6040134.

7.

Benefit of Echocardiography in Patients With Staphylococcus aureus Bacteremia at Low Risk of Endocarditis.

Heriot GS, Tong SYC, Cheng AC, Liew D.

Open Forum Infect Dis. 2018 Dec 11;5(12):ofy303. doi: 10.1093/ofid/ofy303. eCollection 2018 Dec.

8.

Association of good oncological response to therapy with the development of rheumatic immune-related adverse events following PD-1 inhibitor therapy.

Liew DFL, Leung JLY, Liu B, Cebon J, Frauman AG, Buchanan RRC.

Int J Rheum Dis. 2018 Nov 22. doi: 10.1111/1756-185X.13444. [Epub ahead of print]

PMID:
30549256
9.

The role of dihydrosphingolipids in disease.

Magaye RR, Savira F, Hua Y, Kelly DJ, Reid C, Flynn B, Liew D, Wang BH.

Cell Mol Life Sci. 2018 Dec 6. doi: 10.1007/s00018-018-2984-8. [Epub ahead of print] Review.

PMID:
30523364
10.

Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective.

Zomer E, Si S, Hird TR, Liew D, Owen AJ, Tonkin A, Reid CM, Ademi Z.

Eur J Prev Cardiol. 2018 Dec 10:2047487318817910. doi: 10.1177/2047487318817910. [Epub ahead of print]

PMID:
30526023
11.

A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer.

Lindeman GJ, Lok SW, Whittle JR, Vaillant F, Teh CE, Lo LL, Policheni AN, Bergin ART, Desai J, Ftouni S, Gandolfo LC, Liew D, Liu HK, Mann GB, Moodie K, Murugasu A, Pal B, Roberts AW, Rosenthal MA, Shackleton K, Silva MJ, Siow ZR, Smyth GK, Taylor L, Travers A, Yeo B, Yeung MM, Zivanovic Bujak A, Dawson SJ, Gray DHD, Visvader JE.

Cancer Discov. 2018 Dec 5. pii: CD-18-1151. doi: 10.1158/2159-8290.CD-18-1151. [Epub ahead of print]

PMID:
30518523
12.

Characterising risk of in-hospital mortality following cardiac arrest using machine learning: A retrospective international registry study.

Nanayakkara S, Fogarty S, Tremeer M, Ross K, Richards B, Bergmeir C, Xu S, Stub D, Smith K, Tacey M, Liew D, Pilcher D, Kaye DM.

PLoS Med. 2018 Nov 30;15(11):e1002709. doi: 10.1371/journal.pmed.1002709. eCollection 2018 Nov.

13.

Determining the cost of first-ever seizures: A narrative review and future directions.

Foster E, Ademi Z, Lawn N, Chen Z, Carney P, Liew D, O'Brien TJ, Kwan P.

Epilepsy Behav. 2018 Nov 23. pii: S1525-5050(18)30804-7. doi: 10.1016/j.yebeh.2018.10.045. [Epub ahead of print] No abstract available.

PMID:
30477989
14.

Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies.

Chin KL, Ofori-Asenso R, Hopper I, von Lueder TG, Reid CM, Zoungas S, Wang BH, Liew D.

Cardiovasc Res. 2018 Nov 26. doi: 10.1093/cvr/cvy295. [Epub ahead of print]

PMID:
30475996
15.

Switching, Discontinuation, and Reinitiation of Statins Among Older Adults.

Ofori-Asenso R, Ilomaki J, Tacey M, Zomer E, Curtis AJ, Si S, Zullo AR, Korhonen MJ, Bell JS, Zoungas S, Liew D.

J Am Coll Cardiol. 2018 Nov 27;72(21):2675-2677. doi: 10.1016/j.jacc.2018.08.2191. No abstract available.

PMID:
30466527
16.

Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016.

Si S, Ofori-Asenso R, Briffa T, Ilomaki J, Sanfilippo F, Reid CM, Liew D.

J Cardiovasc Pharmacol Ther. 2018 Nov 21:1074248418812184. doi: 10.1177/1074248418812184. [Epub ahead of print]

PMID:
30463435
17.

Predictors of statin use among older adults: A nationwide cross-sectional study.

Ofori-Asenso R, Ilomäki J, Tacey M, Zomer E, Curtis AJ, Bell JS, Zoungas S, Liew D.

J Clin Lipidol. 2018 Oct 16. pii: S1933-2874(18)30422-7. doi: 10.1016/j.jacl.2018.10.002. [Epub ahead of print]

PMID:
30446321
18.

Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.

Mitchell EL, Lau PKH, Khoo C, Liew D, Leung J, Liu B, Rischin A, Frauman AG, Kee D, Smith K, Brady B, Rischin D, Gibson A, Mileshkin L, Klein O, Weickhardt A, Arulananda S, Shackleton M, McArthur G, Östör A, Cebon J, Solomon B, Buchanan RR, Wicks IP, Lo S, Hicks RJ, Sandhu S.

Eur J Cancer. 2018 Dec;105:88-102. doi: 10.1016/j.ejca.2018.09.027. Epub 2018 Nov 13.

PMID:
30439628
19.

Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute Stroke.

Ofori-Asenso R, Zomer E, Chin KL, Si S, Markey P, Tacey M, Curtis AJ, Zoungas S, Liew D.

Int J Environ Res Public Health. 2018 Nov 12;15(11). pii: E2532. doi: 10.3390/ijerph15112532.

20.

Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study.

Ofori-Asenso R, Ilomäki J, Tacey M, Si S, Curtis AJ, Zomer E, Bell JS, Zoungas S, Liew D.

Br J Clin Pharmacol. 2019 Jan;85(1):227-235. doi: 10.1111/bcp.13797. Epub 2018 Nov 8.

PMID:
30402916
21.
22.

Additional structured physical activity does not improve walking in older people (>60years) undergoing inpatient rehabilitation: a randomised trial.

Said CM, Morris ME, McGinley JL, Szoeke C, Workman B, Liew D, Hill KD, Woodward M, Wittwer JE, Churilov L, Danoudis M, Bernhardt J.

J Physiother. 2018 Oct;64(4):237-244. doi: 10.1016/j.jphys.2018.08.006. Epub 2018 Sep 17.

23.

Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective.

Ademi Z, Zomer E, Tonkin A, Liew D.

Int J Cardiol. 2018 Nov 1;270:54-59. doi: 10.1016/j.ijcard.2018.06.091. Epub 2018 Jun 25.

PMID:
30220379
24.

Prescription of physical activity in the management of high blood pressure in Australian general practices.

Smith BJ, Owen AJ, Liew D, Kelly DJ, Reid CM.

J Hum Hypertens. 2018 Sep 4. doi: 10.1038/s41371-018-0098-2. [Epub ahead of print]

PMID:
30181658
25.

Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel.

Batchelor R, Kumar R, Gilmartin-Thomas JFM, Hopper I, Kemp W, Liew D.

Aliment Pharmacol Ther. 2018 Oct;48(8):780-796. doi: 10.1111/apt.14955. Epub 2018 Sep 4. Review.

PMID:
30178881
26.

Recent Patterns of Multimorbidity Among Older Adults in High-Income Countries.

Ofori-Asenso R, Chin KL, Curtis AJ, Zomer E, Zoungas S, Liew D.

Popul Health Manag. 2018 Aug 10. doi: 10.1089/pop.2018.0069. [Epub ahead of print]

PMID:
30096023
27.

Characteristics of national and major regional percutaneous coronary intervention registries: a structured literature review.

Biswas S, Lefkovits J, Liew D, Gale CP, Reid CM, Stub D.

EuroIntervention. 2018 Nov 20;14(10):1112-1120. doi: 10.4244/EIJ-D-18-00434.

28.

Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort.

Gong FF, Jelinek MV, Castro JM, Coller JM, McGrady M, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Owen AJ, Krum H, Reid CM, Prior DL, Campbell DJ.

Open Heart. 2018 Jul 23;5(2):e000782. doi: 10.1136/openhrt-2018-000782. eCollection 2018. Erratum in: Open Heart. 2018 Sep 5;5(2):e000782corr1.

29.

In silico-guided sequence modifications of K-ras epitopes improve immunological outcome against G12V and G13D mutant KRAS antigens.

Ng AWR, Tan PJ, Hoo WPY, Liew DS, Teo MYM, Siak PY, Ng SM, Tan EW, Abdul Rahim R, Lim RLH, Song AAL, In LLA.

PeerJ. 2018 Jul 20;6:e5056. doi: 10.7717/peerj.5056. eCollection 2018.

30.

Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study.

Ho K, Jamsen KM, Bell JS, Korhonen MJ, Mc Namara KP, Magliano DJ, Liew D, Ryan-Atwood TE, Shaw JE, Luc S, Ilomäki J.

Eur J Clin Pharmacol. 2018 Nov;74(11):1493-1501. doi: 10.1007/s00228-018-2518-1. Epub 2018 Jul 19.

PMID:
30027413
31.

GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice.

Furler J, O'Neal DN, Speight J, Blackberry I, Manski-Nankervis JA, Thuraisingam S, de La Rue K, Ginnivan L, Browne JL, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins AJ, Liew D, Clarke P, Best J.

BMJ Open. 2018 Jul 17;8(7):e021435. doi: 10.1136/bmjopen-2017-021435.

32.

Productivity burden of smoking in Australia: a life table modelling study.

Owen AJ, Maulida SB, Zomer E, Liew D.

Tob Control. 2018 Jul 16. pii: tobaccocontrol-2018-054263. doi: 10.1136/tobaccocontrol-2018-054263. [Epub ahead of print]

33.

Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario.

Chowdhury EK, Reid CM, Zomer E, Kelly DJ, Liew D.

Am J Hypertens. 2018 Sep 11;31(10):1156-1163. doi: 10.1093/ajh/hpy108.

PMID:
30010694
34.

Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments.

Petelin L, Liew D, Mitchell G, James PA, Trainer AH.

Value Health. 2018 Jul;21(7):891-893. doi: 10.1016/j.jval.2018.02.009. Epub 2018 May 16. No abstract available.

PMID:
30005762
35.

LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk.

Ofori-Asenso R, Zoungas S, Tonkin A, Liew D.

Clin Pharmacol Ther. 2018 Aug;104(2):235-238. doi: 10.1002/cpt.1125. Epub 2018 Jul 13. No abstract available.

PMID:
30004113
36.

Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With Dementia.

Ofori-Asenso R, Ilomaki J, Tacey M, Curtis AJ, Zomer E, Bell JS, Zoungas S, Liew D.

Am J Alzheimers Dis Other Demen. 2018 Dec;33(8):527-534. doi: 10.1177/1533317518787314. Epub 2018 Jul 10.

PMID:
29991271
37.

Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings from Melbourne Interventional Group Registry.

Chin KL, Tacey M, Reid CM, Tonkin A, Hopper I, Brennan A, Andrianopoulos N, Duffy SJ, Clark D, Ajani AE, Liew D; Melbourne Interventional Group (MIG).

Heart Lung Circ. 2018 Jun 8. pii: S1443-9506(18)30694-2. doi: 10.1016/j.hlc.2018.03.030. [Epub ahead of print]

PMID:
29960835
38.

Observational studies and their utility for practice.

Gilmartin-Thomas JF, Liew D, Hopper I.

Aust Prescr. 2018 Jun;41(3):82-85. doi: 10.18773/austprescr.2018.017. Epub 2018 Jun 1. Review. No abstract available.

39.

Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.

Haridy J, Wigg A, Muller K, Ramachandran J, Tilley E, Waddell V, Gordon D, Shaw D, Huynh D, Stewart J, Nelson R, Warner M, Boyd M, Chinnaratha MA, Harding D, Ralton L, Colman A, Liew D, Iyngkaran G, Tse E; Adelaide Liver Group.

J Viral Hepat. 2018 Nov;25(11):1287-1297. doi: 10.1111/jvh.12943. Epub 2018 Jul 10.

PMID:
29888827
40.

Using technology to support care in gestational diabetes mellitus: Quantitative outcomes of an exploratory randomised control trial of adjunct telemedicine for gestational diabetes mellitus (TeleGDM).

Rasekaba TM, Furler J, Young D, Liew D, Gray K, Blackberry I, Lim WK.

Diabetes Res Clin Pract. 2018 Aug;142:276-285. doi: 10.1016/j.diabres.2018.05.049. Epub 2018 Jun 7.

PMID:
29885390
41.

Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).

Pease A, Earnest A, Ranasinha S, Nanayakkara N, Liew D, Wischer N, Andrikopoulos S, Zoungas S.

Cardiovasc Diabetol. 2018 Jun 2;17(1):77. doi: 10.1186/s12933-018-0726-8.

42.

A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data.

Ofori-Asenso R, Ilomäki J, Zomer E, Curtis AJ, Zoungas S, Liew D.

Cardiovasc Drugs Ther. 2018 Jun;32(3):265-272. doi: 10.1007/s10557-018-6794-x.

PMID:
29790056
43.

The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective.

Kumar R, Tonkin A, Liew D, Zomer E.

Int J Cardiol. 2018 Sep 15;267:183-187. doi: 10.1016/j.ijcard.2018.04.122. Epub 2018 Apr 26.

PMID:
29731350
44.

Reinitiation of Statin Therapy After Discontinuation: A Meta-analysis.

Ofori-Asenso R, Zoungas S, Liew D.

Mayo Clin Proc. 2018 May;93(5):666-668. doi: 10.1016/j.mayocp.2018.01.011. No abstract available. Erratum in: Mayo Clin Proc. 2018 Jul;93(7):960.

PMID:
29728206
45.

Renal safety of short-term empiric gentamicin therapy in aged patients.

Sia CS, Ananda-Rajah MR, Adler NR, Yi-Wei B, Liew D, Tong EY, Aung AK.

Australas J Ageing. 2018 Sep;37(3):227-231. doi: 10.1111/ajag.12541. Epub 2018 Apr 27.

PMID:
29704297
46.

Examination of the relationship between disease activity and patient-reported outcome measures in an inflammatory bowel disease cohort.

Jackson BD, Con D, Gorelik A, Liew D, Knowles S, De Cruz P.

Intern Med J. 2018 Oct;48(10):1234-1241. doi: 10.1111/imj.13937.

PMID:
29663629
47.

Patterns of statin use and long-term adherence and persistence among older adults with diabetes.

Ofori-Asenso R, Ilomäki J, Tacey M, Zomer E, Curtis AJ, Bell JS, Zoungas S, Liew D.

J Diabetes. 2018 Sep;10(9):699-707. doi: 10.1111/1753-0407.12769. Epub 2018 May 10.

PMID:
29658177
48.

Cost of gastroenteritis in Australia: A healthcare perspective.

Barker SF, Zomer E, O'Toole J, Sinclair M, Gibney K, Liew D, Leder K.

PLoS One. 2018 Apr 12;13(4):e0195759. doi: 10.1371/journal.pone.0195759. eCollection 2018.

49.

Chronic pain medication management of older populations: Key points from a national conference and innovative opportunities for pharmacy practice.

Gilmartin-Thomas JF, Bell JS, Liew D, Arnold CA, Buchbinder R, Chapman C, Cicuttini F, Dobbin M, Gibson SJ, Giummarra MJ, Gowan J, Katz B, Lubman DI, McCrone M, Pilgrim J, Synnot A, van Dyk E, Workman B, McNeil J.

Res Social Adm Pharm. 2018 Mar 19. pii: S1551-7411(17)30669-1. doi: 10.1016/j.sapharm.2018.03.060. [Epub ahead of print]

PMID:
29622502
50.

What risk of endocarditis is low enough to justify the omission of transoesophageal echocardiography in Staphylococcus aureus bacteraemia? A narrative review.

Heriot GS, Tong SYC, Cheng AC, Liew D.

Clin Microbiol Infect. 2018 Dec;24(12):1251-1256. doi: 10.1016/j.cmi.2018.03.027. Epub 2018 Mar 23. Review.

PMID:
29581048

Supplemental Content

Support Center